Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015

R. Constance Wiener; Patricia A. Findley; Chan Shen; Nilanjana Dwibedi; Usha Sambamoorthi

doi:10.1016/j.vaccine.2020.05.056

Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015

R. Constance Wiener, Patricia A. Findley, Chan Shen, Nilanjana Dwibedi, Usha Sambamoorthi

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Human papillomavirus (HPV) vaccination acceptance is hampered by fears and conflicting attitudes about the need for and safety of vaccine. There are also ethical dilemmas associated with vaccinating adolescents for a sexually transmitted disease despite future cancer risk. The purpose of this research was to determine HPV vaccination acceptance/hesitancy among young adults. Behavioral Risk Factor Surveillance System 2015 data were used. During 2015, 83.1% of adults ages 25–29 years did not receive any HPV vaccination; the UOR was 3.47; 95% CI = 2.11, 5.70) compared to adults 18–24 years. There is a need to accelerate public health messaging/campaigns to increase HPV vaccination rates.

Original language	English
Pages (from-to)	5119-5122
Number of pages	4
Journal	Vaccine
Volume	38
Issue number	33
DOIs	https://doi.org/10.1016/j.vaccine.2020.05.056
State	Published - 14 Jul 2020

Access to Document

10.1016/j.vaccine.2020.05.056

Cite this

@article{ac4fa44844fb489c8a78f0c0cc8f5bcc,

title = "Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015",

abstract = "Human papillomavirus (HPV) vaccination acceptance is hampered by fears and conflicting attitudes about the need for and safety of vaccine. There are also ethical dilemmas associated with vaccinating adolescents for a sexually transmitted disease despite future cancer risk. The purpose of this research was to determine HPV vaccination acceptance/hesitancy among young adults. Behavioral Risk Factor Surveillance System 2015 data were used. During 2015, 83.1% of adults ages 25–29 years did not receive any HPV vaccination; the UOR was 3.47; 95% CI = 2.11, 5.70) compared to adults 18–24 years. There is a need to accelerate public health messaging/campaigns to increase HPV vaccination rates.",

author = "Wiener, {R. Constance} and Findley, {Patricia A.} and Chan Shen and Nilanjana Dwibedi and Usha Sambamoorthi",

note = "Funding Information: Research reported in this manuscript was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number 5U54GM104942-04 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: {\textcopyright} 2020 Elsevier Ltd",

year = "2020",

month = jul,

day = "14",

doi = "10.1016/j.vaccine.2020.05.056",

language = "English",

volume = "38",

pages = "5119--5122",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "33",

}

TY - JOUR

T1 - Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015

AU - Wiener, R. Constance

AU - Findley, Patricia A.

AU - Shen, Chan

AU - Dwibedi, Nilanjana

AU - Sambamoorthi, Usha

N1 - Funding Information: Research reported in this manuscript was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number 5U54GM104942-04 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: © 2020 Elsevier Ltd

PY - 2020/7/14

Y1 - 2020/7/14

N2 - Human papillomavirus (HPV) vaccination acceptance is hampered by fears and conflicting attitudes about the need for and safety of vaccine. There are also ethical dilemmas associated with vaccinating adolescents for a sexually transmitted disease despite future cancer risk. The purpose of this research was to determine HPV vaccination acceptance/hesitancy among young adults. Behavioral Risk Factor Surveillance System 2015 data were used. During 2015, 83.1% of adults ages 25–29 years did not receive any HPV vaccination; the UOR was 3.47; 95% CI = 2.11, 5.70) compared to adults 18–24 years. There is a need to accelerate public health messaging/campaigns to increase HPV vaccination rates.

AB - Human papillomavirus (HPV) vaccination acceptance is hampered by fears and conflicting attitudes about the need for and safety of vaccine. There are also ethical dilemmas associated with vaccinating adolescents for a sexually transmitted disease despite future cancer risk. The purpose of this research was to determine HPV vaccination acceptance/hesitancy among young adults. Behavioral Risk Factor Surveillance System 2015 data were used. During 2015, 83.1% of adults ages 25–29 years did not receive any HPV vaccination; the UOR was 3.47; 95% CI = 2.11, 5.70) compared to adults 18–24 years. There is a need to accelerate public health messaging/campaigns to increase HPV vaccination rates.

UR - http://www.scopus.com/inward/record.url?scp=85086677624&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2020.05.056

DO - 10.1016/j.vaccine.2020.05.056

M3 - Article

C2 - 32565345

AN - SCOPUS:85086677624

SN - 0264-410X

VL - 38

SP - 5119

EP - 5122

JO - Vaccine

JF - Vaccine

IS - 33

ER -

Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015

Abstract

Access to Document

Other files and links

Fingerprint

Cite this